Technical Analysis for RMTI - Rockwell Medical, Inc.
|Grade||Last Price||% Change||Price Change|
RMTI closed up 10.16 percent on Friday, January 18, 2019, on 75 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
|Weak or Absent||Down||Up||Up|
|See historical RMTI trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||Crossed Above 50 DMA||Bullish||0.00%|
|Jan 18||180 Bullish Setup||Bullish Swing Setup||0.00%|
|Jan 18||Expansion Pivot Buy Setup||Bullish Swing Setup||0.00%|
|Jan 18||Pocket Pivot||Bullish Swing Setup||0.00%|
|Jan 18||Stochastic Reached Overbought||Strength||0.00%|
|Jan 18||Wide Bands||Range Expansion||0.00%|
|Jan 18||Overbought Stochastic||Strength||0.00%|
|Jan 17||50 DMA Resistance||Bearish||10.16%|
|Jan 17||Wide Bands||Range Expansion||10.16%|
|Jan 16||50 DMA Resistance||Bearish||7.76%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. The company offers products and services for the treatment of end-stage renal disease, chronic kidney disease (CKD), iron deficiency, secondary hyperparathyroidism, and hemodialysis (HD). Its products are used to cleanse patients' blood and replace nutrients lost during the kidney dialysis process. The company manufactures, sells, delivers, and distributes HD concentrates, such as CitraPure citric-acid concentrate, Dri-Sate dry acid, Renal Pure liquid acid concentrate, dry acid concentrate mixing system, RenalPure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. It also intends to offer Calcitriol, a generic active vitamin D for the treatment of secondary hyperparathyroidism in dialysis patients. In addition, the company is also developing Soluble Ferric Pyrophosphate, which is in two Phase III clinical trials for iron therapy treatment in CKD-HD patients. Rockwell Medical, Inc. sells its products directly to hemodialysis providers, as well as through independent sales agents and distributors. The company was founded in 1995 and is based in Wixom, Michigan.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more RMTI news...
|52 Week High||6.92|
|52 Week Low||2.19|
|200-Day Moving Average||4.3932|
|50-Day Moving Average||3.2168|
|20-Day Moving Average||2.8975|
|10-Day Moving Average||3.174|
|Average True Range||0.2591|
|Chandelier Exit (Long, 3 ATRs )||2.7727|
|Chandelier Exit (Short, 3 ATRs )||2.9673|
|Upper Bollinger Band||3.5715|
|Lower Bollinger Band||2.2235|
|Percent B (%b)||0.92|
|MACD Signal Line||-0.0365|
|Market Cap||179.54 Million|
|Num Shares||51.7 Million|
|Price-to-Earnings (P/E) Ratio||-8.26|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||4.07|
|Resistance 3 (R3)||4.03||3.79||3.97|
|Resistance 2 (R2)||3.79||3.64||3.81||3.94|
|Resistance 1 (R1)||3.63||3.54||3.71||3.67||3.90|
|Support 1 (S1)||3.23||3.24||3.31||3.27||3.04|
|Support 2 (S2)||2.99||3.14||3.01||3.00|
|Support 3 (S3)||2.83||2.99||2.97|
|Support 4 (S4)||2.87|